Dogs have readily taken PharmAust’s Monepantel tablets using the new formulation for the anti-cancer drug either directly from administrators’ hands or from the floor. This bodes well for future trials of the drug in humans as the canine taste testers have an apparently higher taste sensitivity than humans. The Phase I clinical trial for Monepantel in dogs is poised to start later this month.
11/02/2019 - 09:25
PharmAust’s anti-cancer drug passes canine taste test
By Matt Birney
11/02/2019 - 09:25
Related Data & Insights
-
-
Rank Company Revenue 128th PharmAust $3.8m 137th Adisyn $2.9m 138th rent.com.au $2.8m 141st Douugh $2.5m 142nd Hazer Group $2.4m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
24 Apr 2024
Board Moves, April 24 2024
23 Apr 2024
PharmAust CEO resigns
05 Feb 2024
Board Moves February 5, 2024
28 Aug 2023
Board Moves August 28, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX